scispace - formally typeset
Open AccessJournal ArticleDOI

Small, Dense High-Density Lipoprotein-3 Particles Are Enriched in Negatively Charged Phospholipids Relevance to Cellular Cholesterol Efflux, Antioxidative, Antithrombotic, Anti-Inflammatory, and Antiapoptotic Functionalities

TLDR
In this article, the authors characterized the phosphosphingolipidome of major norm-lipidemic HDL subpopulations and related it to HDL functionality, using an original liquid chromatography-mass spectrometry/mass-spectrometry methodology.
Abstract
Objective—High-density lipoprotein (HDL) displays multiple atheroprotective activities and is highly heterogeneous in structure, composition, and function; the molecular determinants of atheroprotective functions of HDL are incompletely understood. Because phospholipids represent a major bioactive lipid component of HDL, we characterized the phosphosphingolipidome of major normolipidemic HDL subpopulations and related it to HDL functionality. Approach and Results—Using an original liquid chromatography–mass spectrometry/mass spectrometry methodology for phospholipid and sphingolipid profiling, 162 individual molecular lipid species were quantified across the 9 lipid subclasses, in the order of decreasing abundance, phosphatidylcholine>sphingomyelin>lysophosphatidylcholine>phosphatidylethanolamine>phosphatidylinositol>ceramide>phosphatidylserine>phosphatidylglycerol>phosphatidic acid. When data were expressed relative to total lipid, the contents of lysophosphatidylcholine and of negatively charged phospha...

read more

Citations
More filters
Journal ArticleDOI

Dysfunctional HDL and atherosclerotic cardiovascular disease

TL;DR: The proinflammatory enzyme myeloperoxidase induces both oxidative modification and nitrosylation of specific residues on plasma and arterial apolipoprotein A-I to render HDL dysfunctional, which results in impaired ABCA1 macrophage transport, the activation of inflammatory pathways, and an increased risk of coronary artery disease.
Journal ArticleDOI

Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry

TL;DR: This review focuses on state of the art in LC-MS-based lipidomics, covering all the steps of global lipidomic profiling, and concludes that phospholipids followed by sphingomyelins, di- and tri-acylglycerols, and ceramides were the most frequently targeted lipid species.
Journal ArticleDOI

Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease

Paolo Zanoni, +48 more
- 11 Mar 2016 - 
TL;DR: In this paper, the authors identified a homozygote for a loss-of-function variant, in which leucine replaces proline 376 (P376L), in SCARB1, the gene encoding SR-BI.
Journal ArticleDOI

HDL-targeted therapies: progress, failures and future

TL;DR: The HDL hypothesis is examined in molecular and mechanistic terms, focusing on features that have been addressed, those that remain to be tested, and potential new targets for future pharmacological interventions.
Journal ArticleDOI

Sphingolipids and phospholipids in insulin resistance and related metabolic disorders

TL;DR: What is currently known about phospholipid and sphingolipids metabolism in the setting of obesity and how metabolic pathways are being modulated for therapeutic effect are examined.
References
More filters
Journal ArticleDOI

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

TL;DR: A comprehensive survey on the compositional properties of LDL relevant for its susceptibility to oxidation, on the mechanism and kinetics of LDL oxidation, and on the chemical and physico-chemical properties of HDL oxidized by exposure to copper ions is provided.
Journal ArticleDOI

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

TL;DR: Cholesterol efflux capacity from macrophages, a metric of HDL function, has a strong inverse association with both carotid intima-media thickness and the likelihood of angiographic coronary artery disease, independently of the HDL cholesterol level.
Journal ArticleDOI

Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

TL;DR: A preferential increase in circulating concentrations of HDL particles possessing normalized antiatherogenic activity is therefore a promising therapeutic strategy for the treatment of common metabolic diseases featuring dyslipidemia, inflammation, and premature atherosclerosis.
Related Papers (5)

Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study

Benjamin F. Voight, +140 more